![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web |
Hepatitis C |
Free Subscription
3 Eur J Gastroenterol Hepatol |
Retrieve available abstracts of this week’s articles:
HTML format Text format |
Single Articles |
AMEDEO Hepatitis C is free of charge.
Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on
patients with psoriasis.
Eur J Gastroenterol Hepatol. 2019 Jan 29. doi: 10.1097/MEG.0000000000001370.
PubMed
Text format
Abstract available
Effects of antiviral treatment on the risk of hepatocellular cancer in patients
with chronic viral hepatitis.
Eur J Gastroenterol Hepatol. 2018 Sep 1. doi: 10.1097/MEG.0000000000001254.
PubMed
Text format
Abstract available
High proportions of liver fibrosis and cirrhosis in an ageing population of
people who use drugs in Amsterdam, The Netherlands.
Eur J Gastroenterol Hepatol. 2018;30:1168-1176.
PubMed
Text format
Abstract available
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C
Virus-infected Patients without Cirrhosis: OMEGA-1.
Hepatology. 2019 Jan 28. doi: 10.1002/hep.30527.
PubMed
Text format
Abstract available
Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma
Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
PubMed
Text format
Abstract available
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and
non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32
deletion in humanized-liver mice.
J Gastroenterol. 2019 Jan 25. pii: 10.1007/s00535-018-01541.
PubMed
Text format
Abstract available
Time association between hepatitis C therapy and hepatocellular carcinoma
emergence in cirrhosis: relevance of non-characterized nodules.
J Hepatol. 2019 Jan 23. pii: S0168-8278(19)30015.
PubMed
Text format
Abstract available
Clinical outcomes after the introduction of direct antiviral agents for patients
infected with genotype 1b hepatitis C virus depending on the regimens: A
multicenter study in Korea.
J Med Virol. 2019 Jan 29. doi: 10.1002/jmv.25412.
PubMed
Text format
Abstract available
Interferon-free Therapy as the Cause of White Matter Tracts and Cerebral
Perfusion Recovery in Patients with Chronic Hepatitis C.
J Viral Hepat. 2019 Jan 31. doi: 10.1111/jvh.13069.
PubMed
Text format
Abstract available
Testing for hepatitis C virus infection in UK Prisons: what actually happens?
J Viral Hepat. 2019 Jan 31. doi: 10.1111/jvh.13071.
PubMed
Text format
Abstract available
The association between inter-twin birth weight discordance and hepatitis C: The
United States 2011-2015 twin birth registration data.
PLoS One. 2019;14:e0211683.
PubMed
Text format
Abstract available
Increased liver stiffness is associated with mortality in HIV/HCV coinfected
subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
PLoS One. 2019;14:e0211286.
PubMed
Text format
Abstract available
Real life rates of sustained virological response (SVR) and predictors of relapse
following DAA treatment in genotype 3 (GT3) patients with advanced
fibrosis/cirrhosis.
PLoS One. 2018;13:e0200568.
PubMed
Text format
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by